Cholesterol Drugs Zetia and Vytorin: Study Raises Concerns
Submitted by admin on November 16, 2009 – 1:24 pmNo Comment | 28 views
The San Francisco Chronicle reports that a new study raises fresh concerns about Zetia and its cousin, Vytorin — drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work. In the study, Zetia failed to shrink buildups in artery walls while a rival drug, Niaspan, did so significantly. Zetia users also suffered more heart attacks and other problems although the numbers of these events were too small to draw firm conclusions.
Related posts:
